Pfizer Inc financial data

Symbol
PFE on NYSE
Location
66 Hudson Boulevard East, New York, NY
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 4, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 122 % +27.7%
Quick Ratio 29.2 % +15.5%
Debt-to-equity 132 % -8.49%
Return On Equity 10.9 % +132%
Return On Assets 4.7 % +144%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.69B shares +0.33%
Entity Public Float 158B USD -23.7%
Common Stock, Value, Issued 481M USD +0.21%
Weighted Average Number of Shares Outstanding, Basic 5.69B shares +0.32%
Weighted Average Number of Shares Outstanding, Diluted 5.71B shares +0.16%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 62.8B USD +3.89%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 9.15B USD +134%
Income Tax Expense (Benefit) -685M USD -70.4%
Net Income (Loss) Attributable to Parent 9.83B USD +131%
Earnings Per Share, Basic 1 USD/shares +126%
Earnings Per Share, Diluted 1 USD/shares +129%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.34B USD +23%
Accounts Receivable, after Allowance for Credit Loss, Current 14.3B USD -1.32%
Inventory, Net 11.5B USD -2.16%
Other Assets, Current 2.36B USD -38.8%
Assets, Current 46.9B USD +8.56%
Other Long-term Investments 2.14B USD -1.97%
Property, Plant and Equipment, Net 18.9B USD +1.83%
Operating Lease, Right-of-Use Asset 2.29B USD -21.7%
Intangible Assets, Net (Excluding Goodwill) 51.3B USD -14.4%
Goodwill 69.1B USD +0.77%
Other Assets, Noncurrent 9.32B USD -11.1%
Assets 209B USD -4.9%
Accounts Payable, Current 5.02B USD -5.46%
Employee-related Liabilities, Current 3.04B USD -10.3%
Contract with Customer, Liability, Current 924M USD -54.3%
Liabilities, Current 36.6B USD -15.3%
Deferred Income Tax Liabilities, Net 2.47B USD +14.3%
Operating Lease, Liability, Noncurrent 2.29B USD -12.9%
Other Liabilities, Noncurrent 13.6B USD -12.6%
Liabilities 116B USD -8.89%
Accumulated Other Comprehensive Income (Loss), Net of Tax -8.07B USD -1.19%
Retained Earnings (Accumulated Deficit) 121B USD +0.08%
Stockholders' Equity Attributable to Parent 92.8B USD +0.56%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 93.1B USD +0.58%
Liabilities and Equity 209B USD -4.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 2.34B USD +114%
Net Cash Provided by (Used in) Financing Activities -5.23B USD -6%
Net Cash Provided by (Used in) Investing Activities 3.27B USD +89%
Common Stock, Shares Authorized 12B shares 0%
Common Stock, Shares, Issued 9.59B shares +0.32%
Common Stock, Par or Stated Value Per Share 0.05 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 375M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.39B USD +21%
Interest Paid, Excluding Capitalized Interest, Operating Activities 353M USD -14.9%
Deferred Tax Assets, Valuation Allowance 1.64B USD -5.75%
Deferred Tax Assets, Gross 19.1B USD +0.39%
Operating Lease, Liability 2.64B USD -16.2%
Payments to Acquire Property, Plant, and Equipment 564M USD -19.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9.73B USD +129%
Lessee, Operating Lease, Liability, to be Paid 3.2B USD -16.4%
Property, Plant and Equipment, Gross 34.9B USD -0.31%
Operating Lease, Liability, Current 356M USD -32.4%
Operating Lease, Weighted Average Discount Rate, Percent 0.04 pure 0%
Deferred Income Tax Expense (Benefit) -663M USD -50.3%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 556M USD -17.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 27M shares 0%
Unrecognized Tax Benefits 4.53B USD -5.66%
Additional Paid in Capital 94.2B USD +0.83%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 1.2B USD -7.69%
Depreciation, Depletion and Amortization 6.7B USD -5.3%
Deferred Tax Assets, Net of Valuation Allowance 17.5B USD +1.01%
Interest Expense 2.7B USD -11.2%